What is the Abion Inc. stock price forecast?

Abion Inc. is currently trading at ₩1,260. View real-time AI analysis on Alpha Lenz.

What is Abion Inc. insider trading activity?

View the latest insider trading data for Abion Inc. on Alpha Lenz.

What is Abion Inc.'s P/E ratio?

Abion Inc.'s P/E ratio is -3.9.

Abion Inc.

KRX · 203400

₩1,260+35(+2.86%)Market closed

Ask about Abion Inc.'s future dividend policy...

Alpha Chat Insight

“Abion Inc. trades at a P/E of -3.9 (undervalued) with modest ROE of -60.2%.”

Ask for details →

Company Overview

Abion Inc. is a prominent player within the biotechnology industry, specializing in the research, development, and commercialization of innovative therapeutics. The company's primary function is to advance medical science by creating novel treatments for unmet medical needs, focusing particularly on oncology and rare diseases. Abion Inc. is known for its robust patent portfolio and its ability to leverage cutting-edge technologies such as gene editing and cell therapy. These notable features position Abion Inc. at the forefront of transformative trends within the healthcare sector. The company’s work significantly impacts the pharmaceutical and healthcare industries by providing groundbreaking medical solutions that enhance patient care worldwide. Through strategic partnerships and collaborations, Abion Inc. further solidifies its market significance, continuously driving growth and contributing to medical advancements.

CEO신영기

Websitehttps://abionbio.com

SectorHealthcare

IndustryBiotechnology

Employees38

Company Statistics

FY 2025

Profile

₩113,527,643,040Market Cap

₩880,135,980Revenue

90.10MShares Out

38Employees

Margins

35.41%Gross

-2326.58%EBITDA

-2201.04%Operating

-3307.69%Pre-Tax

-3302.16%Net

Valuation

-3.91P/E

1.66P/B

128.99EV/Sales

-4.31EV/EBITDA

-3.39P/FCF

Growth (CAGR)

-29.45%Rev 3Yr

-15.09%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-40.27%ROA

-60.24%ROE

-35.24%ROIC

Financial Health

₩34,369,645,550Cash & Cash Equivalents

₩-22,159,965,120Net Debt

17.86%Debt/Equity

N/AInterest Cov